Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: A randomized, double-blind, controlled study in chronic constipation

Nutrition Journal

Volumn 13, Issue 1, 2014, Pages

  Magro, Daniéla Oliveira ^a   De Oliveira, Lais Mariana R ^a   Bernasconi, Isabela ^a   Ruela, Marilia De Souza ^a   Credidio, Laura ^a   Barcelos, Irene K ^a   Leal, Raquel F ^a   Ayrizono, Maria De Lourdes Stesuko ^a   Fagundes, João José ^a   Teixeira, Leandro De B ^b   Ouwehand, Arthur C ^b   Coy, Claudio S R ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b DUPONT COMPANY   (United States)

Author keywords

Bifidobacterium lactis HN019; Chronic constipation; Lactobacillus acidophilus NCFM

Indexed keywords

GLUCAN; POLYDEXTROSE; PROBIOTIC AGENT; YOGHURT;

ADOLESCENT; ADULT; BIFIDOBACTERIUM; BODY MASS; CHRONIC DISEASE; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTESTINE; LACTOBACILLUS ACIDOPHILUS; MALE; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; BIFIDOBACTERIUM; BODY MASS INDEX; CHRONIC DISEASE; CONSTIPATION; DOUBLE-BLIND METHOD; FEMALE; GLUCANS; HUMANS; INTESTINES; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; PROBIOTICS; YOGURT; YOUNG ADULT;

EID: 84904528270     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-13-75     Document Type: Article

References (30)

1. Pathophysiology of evacuation disorders. Lunniss PJ, Gladman MA, Benninga MA, Rao SS, Neurogastroenterol Motil 2009 Suppl 2 31 40 doi:10.1111/j.1365- 2982.2009.01402.x.
2. Effect of partially hidrolized guar-gum in the treatment of functional constipation among hospitalized patients. Belo GM, Diniz AS, Pereira AP, Arq Gastroenterol 2008 45 93 5 (Pubitemid 351600617)
3. Review of the treatment options for chronic constipation. Johanson JF, MedGenMed 2007 9 25
4. Partially hydrolyzed guar gum: clinical nutrition uses. Slavin JL, Greenberg NA, Nutrition 2003 19 549 52 (Pubitemid 36627442)
5. Gastrointestinal effects and energy value of polydextrose in healthy nonobese men. Achour L, Flourie B, Briet F, Pellier P, Marteau P, Rambaud JC, Am J Clin Nutr 1994 59 1362 8 (Pubitemid 24165891)
6. Effects of polydextrose supplementation on different faecal parameters in healthy volunteers. Hengst C, Ptok S, Roessler A, Fechner A, Jahreis G, Int J Food Sci Nutr 2009 60 Suppl 5 96 105
7. Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Probert HM, Apajalahti JH, Rautonen N, Stowell J, Gibson GR, Appl Environ Microbiol 2004 70 4505 11 (Pubitemid 39095469)
8. Dietary fiber type reflects physiological functionality: comparison of grain fiber, inulin, and polydextrose. Raninen K, Lappi J, Mykkanen H, Poutanen K, Nutr Rev 2011 69 9 21
9. Systematic review of randomised controlled trials: probiotics for functional constipation. Chmielewska A, Szajewska H, World J Gastroenterol 2010 16 69 75
10. Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Buck BL, Altermann E, Svingerud T, Klaenhammer TR, Appl Environ Microbiol 2005 71 8344 51 (Pubitemid 41803962)
11. Probiotics, prebiotics, and synbiotics. De VM, Schrezenmeir J, Adv Biochem Eng Biotechnol 2008 111 1 66
12. Probiotics. Gupta V, Garg R, Indian J Med Microbiol 2009 27 202 9
13. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. Yang YX, He M, Hu G, Wei J, Pages P, Yang XH, Bourdu-Naturel S, World J Gastroenterol 2008 14 6237 43
14. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C, Aliment Pharmacol Ther 2007 26 475 86 (Pubitemid 47063138)
15. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE, Scand J Gastroenterol 2011 46 1057 64
16. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ, Can J Gastroenterol 2003 17 655 9 (Pubitemid 37536846)
17. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC, Pediatr Int 2007 49 485 90
18. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. Banaszkiewicz A, Szajewska H, J Pediatr 2005 146 364 9 (Pubitemid 40341747)
19. Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial. Tabbers MM, Chmielewska A, Roseboom MG, Crastes N, Perrin C, Reitsma JB, Norbruis O, Szajewska H, Benninga MA, Pediatrics 2011 127 1392 1399
20. Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol. Bjorklund M, Ouwehand AC, Forssten SD, Nikkila J, Tiihonen K, Rautonen N, Lahtinen SJ, Age (Dordr) 2012 34 987 99
21. A constipation scoring system to simplify evaluation and management of constipated patients. Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD, Dis Colon Rectum 1996 39 681 5 (Pubitemid 26181138)
22. Chronic constipation. Lembo A, Camilleri M, N Engl J Med 2003 349 1360 8
23. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM, Gut 2010 59 325 32
24. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Khalif IL, Quigley EM, Konovitch EA, Maximova ID, Dig Liver Dis 2005 37 838 49 (Pubitemid 44356113)
25. The intestinal ecosystem in chronic functional constipation. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni ME, Acta Paediatr 1998 87 836 41 (Pubitemid 28409059)
26. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC, Aliment Pharmacol Ther 2002 16 587 93 (Pubitemid 34214540)
27. Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C, Aliment Pharmacol Ther 2005 22 495 512 (Pubitemid 41360796)
28. Bacteria: a new player in gastrointestinal motility disorders - infections, bacterial overgrowth, and probiotics. Quigley EM, Gastroenterol Clin North Am 2007 36 3 735 48 xi (Pubitemid 47575843)
29. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Bueno L, De Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EM, Tack J, Talley NJ, Neurogastroenterol Motil 2007 19 Suppl 1 89 119 (Pubitemid 46058984)
30. Studies on the effects of polydextrose intake on physiologic functions in Chinese people. Jie Z, Bang-Yao L, Ming-Jie X, Hai-Wei L, Zu-Kang Z, Ting-Song W, Craig SA, Am J Clin Nutr 2000 72 1503 9